Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006
Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation
The graduating cohort comprised seven batches across five specialized programs
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
The program expected to commence in August 2026 will be offered across multiple specialised areas with an intake of 20-30 students per course
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Exclusive partnership to expand access to high-quality seamless anodized aluminium packaging for sterile APIs and pharmaceutical products across India.
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
Subscribe To Our Newsletter & Stay Updated
